Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2022-09-22 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and fields related to filing reports of exempt distributions in Canadian jurisdictions. It includes regulatory references to Canadian securities authorities, filing instructions, issuer and underwriter information, and specific securities codes. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a regulatory filing form used to comply with securities regulations rather than a report or announcement of financial results or corporate actions. Therefore, the document fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2022-09-22 English
News release - English.pdf
Regulatory Filings
2022-09-07 English
News release - English.pdf
Regulatory Filings
2022-08-29 English
52-109FV2 - Certification of interim filings - CFO (F).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is 3019 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2022-06-22 English
52-109FV2 - Certification of interim filings - CEO (F).pdf
Regulatory Filings Classification · 95% confidence The document is an attestation by the CEO regarding the interim financial report and management report for the period ended April 30, 2022. It explicitly states it is an attestation for an emerging issuer under Canadian regulation 52-109, confirming the accuracy and fair presentation of the interim financial documents. The text does not contain the actual interim financial statements or substantive financial data but is a certification or attestation letter about those reports. According to the Certification Rule, such attestations should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 3625 characters, which is relatively short and consistent with an attestation letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2022-06-22 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the Interim CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2022. It explicitly states it is a certification related to interim filings, not the filings themselves. The document is short (3099 characters) and primarily an officer certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the interim report itself (IR).
2022-06-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.